Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis
- 15 February 1999
- journal article
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 13 (4) , 400-411
- https://doi.org/10.1101/gad.13.4.400
Abstract
In response to different extracellular signals, Rel/NF-kappaB transcription factors are critical regulators of apoptosis in a variety of cell types. Here we show that in normal B and T cells, expression of the Bcl-2 prosurvival homolog, A1, is rapidly induced in a Rel-dependent manner by mitogens. In B-cell lines derived from c-rel-/- mice, which like primary cells lacking Rel undergo apoptosis in response to antigen receptor ligation, constitutive expression of an A1 transgene inhibits this pathway to cell death. These findings are the first to show that Rel/NF-kappaB regulates physiologically the expression of a Bcl-2-like protein that is critical for the control of cell survival during lymphocyte activation.Keywords
This publication has 58 references indexed in Scilit:
- IEX -1L, an Apoptosis Inhibitor Involved in NF-κB-Mediated Cell SurvivalScience, 1998
- Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell DeathCell, 1996
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994
- Programmed cell death, apoptosis and killer genesImmunology Today, 1993
- High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitroCell, 1993
- The turnover of B-cell populationsImmunology Today, 1993
- PRIMARY RESPONSE GENES INDUCED BY GROWTH FACTORS AND TUMOR PROMOTERSAnnual Review of Biochemistry, 1991
- Site-directed mutagenesis by overlap extension using the polymerase chain reactionGene, 1989
- The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic miceNature, 1985